SCHEMBL12415

SCHEMBL12415

Cc1n[nH]c(C)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17561029 0.73 AKT2 (0.58) —
SCHEMBL15555890 0.71 — —
SCHEMBL11740266 0.69 — —
SCHEMBL600914 0.69 — —
SCHEMBL9126671 0.69 — —
SCHEMBL23240260 0.69 — —
SCHEMBL22339498 0.69 — —
SCHEMBL22421339 0.69 — —
SCHEMBL20844014 0.69 — —
SCHEMBL4889090 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117143150-A Preparation method of chiral 2-hydroxyphosphinic oxide and derivative thereof 广西大学 2023-12-01 — — CN claimed
US-20210253871-A1 CORROSION-RESISTANT CONDUCTIVE STRUCTURE AND CORROSION-RESISTANT COATING COMPOSITION TPK UNIVERSAL SOLUTIONS LIMITED (HK) 2021-08-19 — — US claimed
CN-111192857-A Corrosion-resistant conductive structure and corrosion-resistant coating composition 宸盛光电有限公司 2020-05-22 — — CN claimed
WO-2016123627-A1 ISOQUINILINE AND NAPTHALENE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOUNDS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY (US) 2016-08-04 — — WO claimed
WO-2013037120-A1 LITHIUM CELL HAVING IMPROVED WEIGHT-LOSS CHARACTERISTICS THE GILLETTE COMPANY (US) 2013-03-21 — — WO claimed
US-20120180309-A1 Lithium Primary Cells THE GILLETTE COMPANY, A DELAWARE CORPORATION 2012-07-19 — — US claimed
CN-102047465-A Lithium primary cells GILLETTE CO 2011-05-04 — — CN claimed
EP-2279538-A1 LITHIUM PRIMARY CELLS The Gillette Company (US) 2011-02-02 — — EP claimed
US-7736697-B2 Atomic layer deposition of tantalum-containing films using surface-activating agents and novel tantalum complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-15 — — US claimed
WO-2009148727-A1 LITHIUM PRIMARY CELLS THE GILLETTE COMPANY (US) 2009-12-10 — — WO claimed
US-20090297949-A1 Lithium Primary Cells GILLETTE COMPANY, THE 2009-12-03 — — US claimed
EP-1913173-A2 ATOMIC LAYER DEPOSITION OF TANTALUM-CONTAINING FILMS USING SURFACE-ACTIVATING AGENTS AND NOVEL TANTALUM COMPLEXES E.I.Du pont de nemours and company (US) 2008-04-23 — — EP claimed
WO-2007019436-A2 ATOMIC LAYER DEPOSITION OF TANTALUM-CONTAINING FILMS USING SURFACE-ACTIVATING AGENTS AND NOVEL TANTALUM COMPLEXES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-02-15 — — WO claimed
US-20070036894-A1 forming tantalum nitride layer or tantalum silicide layer; purity; low temperature process for forming a high quality, uniform tantalum-containing films; useful in integrated circuits as barrier films E. I. DU PONT DE NEMOURS AND COMPANY 2007-02-15 — — US claimed
US-5840913-A CATALYTIC N-ALKYLATION OF A PYRAZOLE BY REACTING WITH AN ALCOHOL; LIQUID PHASE; NON-HETEROGENOUS ACID CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1998-11-24 — — US claimed
US-4321395-A Preparation of acetanilides BASF AKTIENGESELLSCHAFT (DE) 1982-03-23 — — US claimed
EP-4712961-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2026-03-25 — — EP disclosed
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2026-01-27 — — US disclosed
EP-0007080-A1 Process for the preparation of N-azolylmethyl-substituted haloacetanilides BASF Aktiengesellschaft (DE) 1980-01-23 — — EP disclosed
US-3957480-A HERBICIDES THE UPJOHN COMPANY (US) 1976-05-18 — — US disclosed
Send feedback